Back
Construction Partners Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Buy
79
ROAD
Construction Partners
Last Price:
71.45
Seasonality Move:
7.05%
Buy
83
MLTX
MoonLake Immunotherapeutics
Last Price:
53.18
Seasonality Move:
10.4%
Buy
79
Construction Partners (ROAD)
is a Buy
Is Construction Partners a Buy, Sell or Hold?
- The current Construction Partners [ROAD] share price is $71.52. The Score for ROAD is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- ROAD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $53.02. The Score for MLTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ROAD Stock Price Chart
What is Construction Partners's stock price today?
-
The Construction Partners share price today is $71.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ROAD is experiencing selling pressure, which indicates risk of future bearish movement.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $53.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight selling pressure.
ROAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.98 | Buy |
| Relative Strength Index (14 RSI): | 70.47 | Buy |
| Chaikin Money Flow: | -198423 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.15 - 66.55) | Buy |
| Bollinger Bands (100): | (54.05 - 62.45) | Buy |
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | -49117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.38 - 50.14) | Buy |
| Bollinger Bands (100): | (40.67 - 47.33) | Buy |
ROAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.59 | Buy |
| 20-day SMA: | 63.21 | Buy |
| 50-day SMA: | 61.01 | Buy |
| 200-day SMA: | 53.03 | Buy |
| 8-day EMA: | 66.29 | Buy |
| 20-day EMA: | 63.61 | Buy |
| 50-day EMA: | 61.21 | Buy |
| 200-day EMA: | 53.4 | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.49 | Buy |
| 20-day SMA: | 48.24 | Buy |
| 50-day SMA: | 46.5 | Buy |
| 200-day SMA: | 48.46 | Buy |
| 8-day EMA: | 50.08 | Buy |
| 20-day EMA: | 48.49 | Buy |
| 50-day EMA: | 46.7 | Buy |
| 200-day EMA: | 45.76 | Buy |
Construction Partners Earnings Growth & ROAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.50 per share, an increase this year of $0.57 per share, and an increase next year of $0.37 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Construction Partners Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MoonLake Immunotherapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||